CW February 2005

category image Volume 14
Issue Number 2
February 2005
ISSN 10593802

Next-Generation Nucleoside Analogue Active In Refractory Childhood Leukemias

A next-generation nucleoside analogue, clofarabine, is active as a single agent in pediatric acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML) refractory to intensive salvage regimens.
Go to Previous Page
Go to Next Page

Source & Additional Reading

Sima Jeha, American Society of Hematology annual meeting.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW February 2005

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login